Greg Rossi, Ph.D., is the Senior Vice President responsible for the Oncology Business Unit in Europe and Canada at AstraZeneca. He received his doctorate in Biochemical Engineering from University College London (UCL) and has worked since then in the biotechnology/pharmaceutical industry in the clinical development and commercialisation of oncology therapeutics.
Over the last 25 years, Greg has worked in a number of national, regional (Europe) and global roles for Amgen, Genentech, Roche and finally AstraZeneca. Immediately before taking over the management of the Europe and Canada oncology business at AstraZeneca, Greg was responsible for the company’s global Immuno-Oncology franchise.
Updated: June 2022